| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 135, 169-175, Copyright © 1989 by American Society for Investigative Pathology
REGULAR ARTICLES |
GK Hansson, J Holm and L Jonasson
Department of Clinical Chemistry, Gothenburg University, Sweden.
It was recently shown that the human atherosclerotic plaque contains significant amounts of T lymphocytes, and also that smooth muscle cells in these plaques express class II MHC (Ia) antigens. These antigens are not normally present on smooth muscle cells but are inducible by interferon-gamma, a secretory product of activated T cells. Therefore, T cell activation in the plaque was analyzed by immunofluorescent detection of activation markers on T cells isolated from the plaques and in cryostat sections of carotid endarterectomy specimens. Of cells isolated from the plaque, 5% exhibited the E rosettes characteristic of T cells. One third of these cells expressed HLA-DR and VLA-1 (very late activation antigen-1), which in T cells are synthesized only in the activated state. T cells were also identified in sections using immunofluorescent detection of the T cell-specific surface protein, CD3 (Leu-4), with rhodamine labeled second-step antibodies. The frequency of activated T cells was then determined by staining the same, or serial, sections with antibodies to HLA-DR or to the interleukin-2 receptor, followed by biotin-avidin-FITC detection. Of the T cells in the plaque, 34% and 6%, respectively, expressed these cell surface proteins. Taken together, these results indicated that a substantial proportion of the T cells in atherosclerotic plaque are in an activated state. The activation pattern, with a high frequency of HLA-DR and VLA- 1 expression and a much lower frequency of interleukin-2 receptor expression, was similar to that reported to occur in chronic inflammatory conditions. Interferon-gamma could be detected in and around some of the lymphocytes, suggesting that paracrine secretion of this lymphokine may occur in the plaque. T cells may be activated locally, presumably by antigen(s) presented in the context of class II MHC expressing smooth muscle cells and/or macrophages, in the atherosclerotic lesion. Such activated T cells may in turn modulate the functions of other cells in the plaque.
This article has been cited by other articles:
 |
|
 |
|
  J Frostegard Systemic lupus erythematosus and cardiovascular disease Lupus, May 1, 2008; 17(5): 364 - 367. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Li Platelet-lymphocyte cross-talk J. Leukoc. Biol., May 1, 2008; 83(5): 1069 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Gotsman, R. Gupta, and A. H. Lichtman The Influence of the Regulatory T Lymphocytes on Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2493 - 2495. [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. King, L. A. Cassis, and A. Daugherty Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice Am. J. Pathol., December 1, 2007; 171(6): 2040 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Krebs, E. Scandella, B. Bolinger, D. Engeler, S. Miller, and B. Ludewig Chronic Immune Reactivity Against Persisting Microbial Antigen in the Vasculature Exacerbates Atherosclerotic Lesion Formation Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2206 - 2213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Gotsman and A. H. Lichtman Targeting Interferon-{gamma} to Treat Atherosclerosis Circ. Res., August 17, 2007; 101(4): 333 - 334. [Full Text] [PDF]
|
|
|
|
|
|
A.-K. L. Robertson and G. K Hansson T Cells in Atherogenesis: For Better or For Worse? Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2421 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Ranjit and L Dazhu Potential role of dendritic cells for progression of atherosclerotic lesions. Postgrad. Med. J., September 1, 2006; 82(971): 573 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pryshchep, K. Sato, J. J. Goronzy, and C. M. Weyand T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome Circ. Res., May 12, 2006; 98(9): 1168 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nigro, N. Osman, A. M. Dart, and P. J. Little Insulin Resistance and Atherosclerosis Endocr. Rev., May 1, 2006; 27(3): 242 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sharma and D.-Z. Li Role of Dendritic Cells in Atherosclerosis Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 166 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhou, A.-K. L. Robertson, C. Hjerpe, and G. K. Hansson Adoptive Transfer of CD4+ T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 864 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sato, A. Niessner, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque J. Exp. Med., January 23, 2006; 203(1): 239 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Meyer, M. H. Creer, and J. McHowat Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1485 - C1491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P R. Ames, C Tommasino, G Fossati, E Matsuura, A Margarita, A Saulino, L Lopez, G Scenna, and V Brancaccio Lymphocyte subpopulations and intima media thickness in primary antiphospholipd syndrome Lupus, October 1, 2005; 14(10): 809 - 813. [Abstract] [PDF]
|
|
|
|
|
|
V. C. Mehra, V. S. Ramgolam, and J. R. Bender Cytokines and cardiovascular disease J. Leukoc. Biol., October 1, 2005; 78(4): 805 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frostegard Atherosclerosis in Patients With Autoimmune Disorders Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1776 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Duftner, R. Seiler, P. Klein-Weigel, H. Gobel, C. Goldberger, C. Ihling, G. Fraedrich, and M. Schirmer High Prevalence of Circulating CD4+CD28- T-Cells in Patients With Small Abdominal Aortic Aneurysms Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1347 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Methe, S. Brunner, D. Wiegand, M. Nabauer, J. Koglin, and E. R. Edelman Enhanced T-Helper-1 Lymphocyte Activation Patterns in Acute Coronary Syndromes J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1939 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Raines and N. Ferri Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease J. Lipid Res., June 1, 2005; 46(6): 1081 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wessely Interference by interferons: Janus faces in vascular proliferative diseases Cardiovasc Res, June 1, 2005; 66(3): 433 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Hansson Inflammation, Atherosclerosis, and Coronary Artery Disease N. Engl. J. Med., April 21, 2005; 352(16): 1685 - 1695. [Full Text] [PDF]
|
|
|
|
|
|
C. Tenger, A. Sundborger, J. Jawien, and X. Zhou IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-{gamma} and CXCL16 Expression Independently of T Cells Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 791 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Chan, N. Pejnovic, H. Hamilton, T. V. Liew, D. Popadic, A. Poggi, and S. M. Khan Atherosclerotic Abdominal Aortic Aneurysm and the Interaction Between Autologous Human Plaque-Derived Vascular Smooth Muscle Cells, Type 1 NKT, and Helper T Cells Circ. Res., April 1, 2005; 96(6): 675 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhou, A.-K. L. Robertson, M. Rudling, P. Parini, and G. K. Hansson Lesion Development and Response to Immunization Reveal a Complex Role for CD4 in Atherosclerosis Circ. Res., March 4, 2005; 96(4): 427 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Buono, C. J. Binder, G. Stavrakis, J. L. Witztum, L. H. Glimcher, and A. H. Lichtman T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses PNAS, February 1, 2005; 102(5): 1596 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W Wong, T. Christen, and B. R Kwak Connexins in leukocytes: shuttling messages? Cardiovasc Res, May 1, 2004; 62(2): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, M. Sakuma, A. C. Zago, X. Zhang, C. Shi, L. Leng, Y. Mizue, R. Bucala, and D. I. Simon Evidence for a Role of Macrophage Migration Inhibitory Factor in Vascular Disease Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 709 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Wuttge, X. Zhou, Y. Sheikine, D. Wagsater, V. Stemme, U. Hedin, S. Stemme, G. K. Hansson, and A. Sirsjo CXCL16/SR-PSOX Is an Interferon-{gamma}-Regulated Chemokine and Scavenger Receptor Expressed in Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 750 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Stokes, E. C. Clanton, J. L. Gehrig, and D. N. Granger Role of interleukin 12 in hypercholesterolemia-induced inflammation Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2623 - H2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. J de Boer, A. E Becker, and A. C van der Wal T lymphocytes in atherogenesis--functional aspects and antigenic repertoire Cardiovasc Res, October 15, 2003; 60(1): 78 - 86. [Full Text] [PDF]
|
|
|
|
|
|
W. Cao, Y. V Bobryshev, R. S.A Lord, R. E.I Oakley, S. H Lee, and J. Lu Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis Cardiovasc Res, October 15, 2003; 60(1): 175 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Tousoulis, G Davies, C Stefanadis, P Toutouzas, and J A Ambrose Inflammatory and thrombotic mechanisms in coronary atherosclerosis Heart, September 1, 2003; 89(9): 993 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-P. Yang, L.-J. Ho, Y.-L. Lin, S.-M. Cheng, T.-P. Tsao, D.-M. Chang, Y.-L. Hsu, C.-Y. Shih, T.-Y. Juan, and J.-H. Lai Carvedilol, a new antioxidative {beta}-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-{kappa}B activity Cardiovasc Res, September 1, 2003; 59(3): 776 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Elhage, J. Jawien, M. Rudling, H.-G. Ljunggren, K. Takeda, S. Akira, F. Bayard, and G. K Hansson Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice Cardiovasc Res, July 1, 2003; 59(1): 234 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Benagiano, A. Azzurri, A. Ciervo, A. Amedei, C. Tamburini, M. Ferrari, J. L. Telford, C. T. Baldari, S. Romagnani, A. Cassone, et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions PNAS, May 27, 2003; 100(11): 6658 - 6663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Soejima, A. Irie, S. Miyamoto, I. Kajiwara, S. Kojima, J. Hokamaki, T. Sakamoto, T. Tanaka, M. Yoshimura, Y. Nishimura, et al. Preference Toward a T-Helper Type 1 Response in Patients With Coronary Spastic Angina Circulation, May 6, 2003; 107(17): 2196 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Virella, S. R. Thorpe, N. L. Alderson, E. M. Stephan, D. Atchley, F. Wagner, and M. F. Lopes-Virella Autoimmune response to advanced glycosylation end-products of human LDL J. Lipid Res., March 1, 2003; 44(3): 487 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Xia, W. H. Ling, J. Ma, D. D. Kitts, and J. Zawistowski Supplementation of Diets with the Black Rice Pigment Fraction Attenuates Atherosclerotic Plaque Formation in Apolipoprotein E Deficient Mice J. Nutr., March 1, 2003; 133(3): 744 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Buono, C. E. Come, G. Stavrakis, G. F. Maguire, P. W. Connelly, and A. H. Lichtman Influence of Interferon-{gamma} on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient Mouse Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 454 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Naruszewicz, M.-L. Johansson, D. Zapolska-Downar, and H. Bukowska Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1249 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Spagnoli, E. Bonanno, A. Mauriello, G. Palmieri, A. Partenzi, G. Sangiorgi, and F. Crea Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1579 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Viedt, J. Vogel, T. Athanasiou, W. Shen, S. R. Orth, W. Kubler, and J. Kreuzer Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-{kappa}B and Activator Protein-1 Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 914 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. George, A. Afek, P. Keren, I. Herz, I. Goldberg, R. Haklai, Y. Kloog, and G. Keren Functional Inhibition of Ras by S-trans,trans-Farnesyl Thiosalicylic Acid Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice Circulation, May 21, 2002; 105(20): 2416 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Q. Wang, C. G. Panousis, M. L. Alfaro, G. F. Evans, and S. H. Zuckerman Interferon-{gamma}-Mediated Downregulation of Cholesterol Efflux and ABC1 Expression Is by the Stat1 Pathway Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): e5 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Rolph, S. Zimmer, B. Bottazzi, C. Garlanda, A. Mantovani, and G. K. Hansson Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): e10 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Monaco, E. Andreakos, S. Young, M. Feldmann, and E. Paleolog T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor J. Leukoc. Biol., April 1, 2002; 71(4): 659 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. King, S. J. Szilvassy, and A. Daugherty Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor-/- Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 456 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhang, X. Zeng, J. Guo, and X. Wang Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes Cardiovasc Res, March 1, 2002; 53(4): 1035 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Pockley Heat Shock Proteins, Inflammation, and Cardiovascular Disease Circulation, February 26, 2002; 105(8): 1012 - 1017. [Full Text] [PDF]
|
|
|
|
|
|
B. R. Kwak, S. Myit, F. Mulhaupt, N. Veillard, N. Rufer, E. Roosnek, and F. Mach PPAR{gamma} but not PPAR{alpha} Ligands Are Potent Repressors of Major Histocompatibility Complex Class II Induction in Atheroma-Associated Cells Circ. Res., February 22, 2002; 90(3): 356 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Haranaga, H. Yamaguchi, H. Friedman, S.-i. Izumi, and Y. Yamamoto Chlamydia pneumoniae Infects and Multiplies in Lymphocytes In Vitro Infect. Immun., December 1, 2001; 69(12): 7753 - 7759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. George, A. Afek, A. Shaish, H. Levkovitz, N. Bloom, T. Cyrus, L. Zhao, C. D. Funk, E. Sigal, and D. Harats 12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor-Deficient Mice Circulation, October 2, 2001; 104(14): 1646 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. George, A. Afek, B. Gilburd, Y. Shoenfeld, and D. Harats Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice J. Am. Coll. Cardiol., September 1, 2001; 38(3): 900 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Valen, Z.-q. Yan, and G.o. K. Hansson Nuclear factor kappa-B and the heart J. Am. Coll. Cardiol., August 1, 2001; 38(2): 307 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Laurat, B. Poirier, E. Tupin, G. Caligiuri, G.K. Hansson, J. Bariety, and A. Nicoletti In Vivo Downregulation of T Helper Cell 1 Immune Responses Reduces Atherogenesis in Apolipoprotein E-Knockout Mice Circulation, July 10, 2001; 104(2): 197 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. van der Loos, M. A. Houtkamp, O. J. de Boer, P. Teeling, A. C. van der Wal, and A. E. Becker Immunohistochemical Detection of Interferon-{{gamma}}: Fake or Fact? J. Histochem. Cytochem., June 1, 2001; 49(6): 699 - 710. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. J. Tegos, E. Kalodiki, M. M. Sabetai, and A. N. Nicolaides The Genesis of Atherosclerosis and Risk Factors: A Review Angiology, February 1, 2001; 52(2): 89 - 98. [Abstract] [PDF]
|
|
|
|
|
|
R. De Caterina, T. Bourcier, U. Laufs, V. La Fata, G. Lazzerini, A. S. Neish, P. Libby, and J. K. Liao Induction of Endothelial-Leukocyte Interaction by Interferon-{{gamma}} Requires Coactivation of Nuclear Factor-{{kappa}}B Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 227 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhou, G. Caligiuri, A. Hamsten, A. K. Lefvert, and G. K. Hansson LDL Immunization Induces T-Cell-Dependent Antibody Formation and Protection Against Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wu, C. Lemne, U. de Faire, and J. Frostegard Antibodies to Lysophosphatidylcholine Are Decreased in Borderline Hypertension Hypertension, January 1, 2001; 37(1): 154 - 159. [Abstract] [Full Text] |
